Page 334 - HIVMED_v21_i1.indb
P. 334

Page 5 of 5  Original Research


              The time has come for HIV treatment programmes to draw   4.  Asiki  G,  Reniers  G,  Newton  R,  et  al.  Adult  life  expectancy  trends  in  the  era
              on a wide range of medical disciplines and evidence-based   of  antiretroviral  treatment  in  rural  Uganda  (1991–2012).  AIDS.  2016;30(3):
                                                                      487–493.
              screening procedures for the multidisciplinary care of the   5.  Harris  TG,  Rabkin  M,  El-Sadr  WM.  Achieving  the  fourth  90:  Healthy  aging  for
              ageing HIV-infected population. Age-appropriate monitoring   people living with HIV. AIDS. 2018;32(12):1563–1569. https://doi.org/10.1097/
                                                                      QAD.0000000000001870
              protocols must be developed to ensure optimum quality of   6.  Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an
              care for elderly HIV-positive individuals.              ageing  population  infected  with  HIV:  A  modelling  study.  Lancet  Infect  Dis.
                                                                      2015;15(7):810–818. https://doi.org/10.1016/S1473-3099(15)00056-0
              Acknowledgements                                      7.  Greene M, Covinsky KE, Valcour V, et al. Geriatric syndromes in older HIV-infected
                                                                      adults.  J  AIDS.  2015;69(2):161–167.  https://doi.org/10.1097/QAI.00000000000
                                                                      00556
              The authors would like to acknowledge Newlands Clinic   8.  Wing  EJ.  HIV  and  aging.  Int  J  Infect  Dis.  2016;53(1):61–68.  https://doi.org/
                                                                      10.1016/j.ijid.2016.11.414
              staff and patients. Furthermore, we acknowledge Morna   9.  Jilich D, Sedl S, Nielsen LN, et al. Infection-related and -unrelated malignancies,
              Cornell who mentored us during the writing process.     HIV and the aging population. HIV Med. 2016;17(8):590–600.
                                                                    10. Agaba PA, Meloni ST, Sule HM, et al. Treatment outcomes among older human
                                                                      immunodeficiency  virus-infected  adults  in  Nigeria.  Open  Forum  Infect  Dis.
              Competing interests                                     2017;4(2):ofx031. https://doi.org/10.1093/ofid/ofx031
                                                                    11. Cornell  M,  Johnson  LF,  Schomaker  M,  et  al.  Age  in  antiretroviral  therapy
              The authors have no competing interests to declare.     programmes in South Africa: A retrospective, multicentre, observational cohort
                                                                      study.  Lancet  HIV.  2015;2(9):368–375.  https://doi.org/10.1016/S2352-3018(15)
                                                                      00113-7
              Authors’ contributions                                12. Brañas F, Sánchez-Conde M, Carli F, et al. Sex differences in people aging with HIV.
                                                                      J Acquir Immune Defic Syndr. 2020;83(3):284–291. https://doi.org/10.1097/QAI.
              All authors were involved in designing the study. T.S. and   0000000000002259
              C.C. conducted the data analysis. C.C. prepared the draft   13. Shamu T, Chimbetete C, Shawarira-Bote S, Mudzviti T, Luthy R. Outcomes of an
                                                                      HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare,
              manuscript. T.S. and T.M. reviewed the draft manuscript.   Zimbabwe:  TENART  cohort.  PLoS  One.  2017;12(10):e0186726.  https://doi.org/
                                                                      10.1371/journal.pone.0186726
              C.C. prepared the final manuscript for publication.   14. Ghidei L, Simone M, Salow M, et al. Aging, antiretrovirals, and adherence: A meta
                                                                      analysis  of  adherence  among  older  HIV-infected  individuals.  Drugs  Aging.
                                                                      2013;30(10):809–819. https://doi.org/10.1007/s40266-013-0107-7
              Funding information                                   15. Soomro N, Fitzgerald G, Seeley J, Schatz E, Nachega JB, Negin J. Comparison of
                                                                      antiretroviral therapy adherence among HIV-infected older adults with younger
              Study did not receive any funding. Analysis is conducted as   adults in Africa: Systematic review and meta-analysis. AIDS Behav. 2019;23(2):
              part of the routine clinic work.                        445–458. https://doi.org/10.1007/s10461-018-2196-0
                                                                    16. Carr  D.  Marital  transitions:  Widowhood,  divorce,  and  remarriage.  In:
                                                                      Whitbourne SK, editors. The encyclopedia of adulthood and aging. Hoboken,
                                                                      NJ: John Wiley & Sons, 2015; p. 1–5.
              Data availability statement                           17. Heestermans  T,  Browne  JL,  Aitken  SC,  Vervoort  SC,  Klipstein-Grobusch  K.
                                                                      Determinants of adherence to antiretroviral therapy among HIV-positive adults in
              The data sets used and/or analysed during the current study   sub-Saharan  Africa:  A  systematic  review.  BMJ  Glob  Health.  2016;1(4):1–13.
              are available from the corresponding author upon request.  https://doi.org/10.1136/bmjgh-2016-000125
                                                                    18. Nguyen  KA,  Peer  N,  Mills  EJ,  Kengne  AP.  Burden,  determinants,  and
                                                                      pharmacological  management  of  hypertension  in  HIV-positive  patients  and
              Disclaimer                                              populations: A systematic narrative review. AIDS Rev. 2015;17(2):83–95.
                                                                    19. Abraham AG, Crane AH, Eron J, et al. End-stage renal disease among HIV-infected
              The views expressed in this article are those of the authors’   adults  in  North  America.  Clin  Infect  Dis.  2015;60(6):941–949.  https://doi.
                                                                      org/10.1093/cid/ciu919
              and do not necessarily reflect the official policy or position of   20. Rasmussen LD, Mathiesen ER, Kronborg G, Gerstoft J, Obel N. Risk of diabetes
              any affiliated agency of the authors.                   mellitus in persons with and without HIV: A Danish nationwide population-based
                                                                      cohort  study.  PLoS  One.  2012;7(9):e44575.  https://doi.org/10.1371/journal.
                                                                      pone.0044575
              References                                            21. Monroe  AK,  Glesby  MJ,  Brown  TT.  Diagnosing  and  managing  diabetes  in  HIV-
                                                                      infected patients: Current concepts. Clin Infect Dis. 2015;60(3):453–462. https://
                                                                      doi.org/10.1093/cid/ciu779
              1.  Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional
                trends of people living with HIV aged 50 and over: Estimates and projections for   22. Lin SP, Wu CY, Wang CB, Li TC, Ko NY, Shi ZY. Risk of diabetes mellitus in HIV-
                2000–2020. PLoS One. 2018;13(11):e0207005. https://doi.org/10.1371/journal.  infected  patients  receiving  highly  active  antiretroviral  therapy:  A  nationwide
                pone.0207005                                          population-based study. Medicine (Baltimore). 2018;97(36):e12268. https://doi.
                                                                      org/10.1097/MD.0000000000012268
              2.  Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults
                on antiretroviral therapy across the globe: Comparisons with general population.   23. Palefsky JM. HPV-associated anal and cervical cancers in HIV-infected individuals:
                Curr  Opin  HIV  AIDS.  2016;11(5):492–500.  https://doi.org/10.1097/COH.00000   Incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS.
                00000000298                                           2017;12(1):26–30. https://doi.org/10.1097/COH.0000000000000336
              3.  Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of   24. Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative incidence of cancer among
                HIV-positive  people  after  starting  combination  antiretroviral  therapy:  A  meta-  persons  with  HIV  in  North  America:  A  cohort  study.  Ann  Intern  Med.
                analysis. HIV Med. 2017;18(4):256–266. https://doi.org/10.1111/hiv.12421  2015;163(7):507–518. https://doi.org/10.7326/M14-2768
















                                           http://www.sajhivmed.org.za 326  Open Access
   329   330   331   332   333   334   335   336   337   338   339